摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone

中文名称
——
中文别名
——
英文名称
[(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone
英文别名
——
[(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone化学式
CAS
——
化学式
C28H32N2O4
mdl
——
分子量
460.6
InChiKey
LOFNUDFEVFRHRS-XJVVAUETSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    34
  • 可旋转键数:
    3
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    73.2
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • MORPHINAN DERIVATIVE
    申请人:The Kitasato Institute
    公开号:EP2774926A1
    公开(公告)日:2014-09-10
    A morphinan derivative represented by the following general formula (I): (in the formula, R1 represents hydrogen, C1-6 alkyl, cycloalkylalkyl (the cycloalkyl moiety has 3 to 6 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms), aralkyl (the aryl moiety has 6 to 10 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms) and the like, R2 represents hydrogen, C1-6 alkyl, C3-6 cycloalkyl, C6-10 aryl, aralkyl (the aryl moiety has 6 to 10 carbon atoms, and the alkylene moiety has 1 to 5 carbon atoms) and the like, R3, R4 and R5 represent hydrogen, hydroxy, carbamoyl, C1-6 alkoxy, C6-10 aryloxy and the like, R6a, R6b, R7, R8, R9, and R10 represent hydrogen and the like, X represents O or CH2, and Y represents C=O, SO2, an atomic bond and the like), or an acid addition salt thereof is used as an analgesic.
    由以下通式 (I) 代表的吗啡南衍生物: (式中,R1 代表氢、C1-6 烷基、环烷基(环烷基有 3 至 6 个碳原子,亚烷基有 1 至 5 个碳原子)、芳烷基(芳基有 6 至 10 个碳原子,亚烷基有 1 至 5 个碳原子)等、 R2 代表氢、C1-6 烷基、C3-6 环烷基、C6-10 芳基、芳烷基(芳基有 6 至 10 个碳原子,亚烷基有 1 至 5 个碳原子)等、 R3、R4 和 R5 代表氢、羟基、氨基甲酰基、C1-6 烷氧基、C6-10 芳氧基等、 R6a、R6b、R7、R8、R9 和 R10 代表氢等、 X 代表 O 或 CH2,以及 Y 代表 C=O、SO2、原子键等)或其酸加成盐用作镇痛剂。
查看更多

同类化合物

普罗啡烷 (9R,10R)-15-(环丙基甲基)-10-甲基-11-氧杂-17-氮杂四环[7.5.3.01,10.0(2,7)]十七-2,4,6-三烯-4-醇 3-methoxy-14β-hydroxy-6-oxamorphinan (1S,3aR,5aS,6R,11bR,11cS)-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indole (+)-14β-Hydroxy-3-methoxy-17-methyl-6-oxamorphinan N-Propargyl-3-methoxy-14β-methyl-8-oxamorphinan N-Propargyl-3-hydroxy-14β-methyl-8-oxamorphinan NS 28 17-cyclopropylmethyl-7,14α-epoxy-7,14-seco-8-nor-morphinan-3-ol 17-cyclopropylmethyl-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-phenyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one NS22 (1S,5R,13R,14R,17S)-4-methyl-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-trien-10-ol KNT-63 (1R,9R,10S,13R)-18-(cyclopropylmethyl)-4-hydroxy-19-oxa-18-azapentacyclo[7.6.3.1^{10,13}.0^{1,10}.0^{2,7}]nonadeca-2(7),3,5-trien-14-one (1S,9R,10R)-17-(cyclopropylmethyl)-11-hydroxy-4-methoxy-12-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-13-one 17-cyclopropylmethyl-6α,14-epoxy-4,5α-epoxy-3-benzyloxymorphinan Proxorphan tartrate (1S,3aS,5aS,6R,11bR,11cR)-3-benzyl-14-(cyclopropylmethyl)-3a,11-dihydroxy-10-methoxy-1,3,3a,4,5,6,7,11c-octahydro-2H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-2-one (4bR,8R,8aS,9aS,11aS,11bR)-7-allyl-11-benzyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-methyl-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-1-hydroxy-7-isobutyl-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (4bR,8R,8aS,9aS,11aS,11bR)-7-(cyclopropylmethyl)-1-hydroxy-11-(2-phenethyl)-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one (1S,5R,13R,14R,17S)-4-(cyclopropylmethyl)-10-methoxy-12,19-dioxa-4-azahexacyclo[9.6.1.114,17.01,13.05,17.07,18]nonadeca-7(18),8,10-triene (4bR,8R,8aS,9aS,11aS,11bR)-11-benzyl-7-(cyclopropylmethyl)-1-hydroxy-5,6,7,8,9a,11b-hexahydro-8a,11a-ethano-4,8-methano-9,12,14-trioxa-7,11-diazabenzo[a]benzo[4,5]cycloocta[1,2,3-gh]pentalen-10(11H)-one 3-methoxy-10α,17-dimethyl-6-oxamorphinan 3-methoxy-17-methyl-10-methylene-6-oxamorphinan rac-7,14α-epoxy-3-methoxy-7,14-seco-8-nor-morphinane (1R,9S,10S)-17-(cyclopropylmethyl)-13-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10R)-10,17-dimethyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol (1S,9R,10S)-17-(cyclopropylmethyl)-10-methyl-11-oxa-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol 16-(Cyclopropylmethyl)-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 3-Hydroxy-17-methyl-8-oxamorphinan 12,16-Dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol rac-(6Ξ)-6,14β-epoxy-17-methyl-7,14-seco-8-nor-morphinane (1R,9R,10S)-16-cyclobutyl-10,12-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2(7),3,5-trien-4-ol 1-[(1R,9R,10S)-10,16-dimethyl-11-oxa-16-azatetracyclo[7.4.3.01,10.02,7]hexadeca-2,4,6-trien-12-yl]-N,N-dimethylmethanamine;hydrochloride (8S)-6-benzyl-21-(cyclopropylmethyl)-15-hydroxy-11,13,25-trioxa-6,21-diazahexacyclo[12.9.1.12,8.01,9.02,20.018,24]pentacosa-14,16,18(24)-trien-7-one (3S)-5,20-bis(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (3S)-5-benzyl-20-(cyclopropylmethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-16-ol [(3R,6S)-14-hydroxy-19-(2-hydroxy-2-methylpropyl)-7-oxa-4,19-diazahexacyclo[7.7.3.13,8.01,8.02,6.011,16]icosa-11(16),12,14-trien-4-yl]-phenylmethanone [(3S)-20-(cyclopropylmethyl)-5-(4,6-dimethyl-1,2-dihydropyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-yl] trifluoromethanesulfonate 3-[(3S)-20-(cyclopropylmethyl)-15-methoxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-triene-5-carbonyl]benzonitrile [(3S)-20-(cyclopropylmethyl)-15-hydroxy-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-5-yl]-(2-fluorophenyl)methanone (1R,3S,9S,10R)-20-(cyclopropylmethyl)-5-(4,6-dimethylpyrimidin-2-yl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-2,3,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-11-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-10-methoxy-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(iminoethano)-1,5a-epoxynaphtho[1,2-e]indol-12-ol (1R,2S,3S,6R,9S,10R)-20-(cyclopropylmethyl)-5-(2-phenylethyl)-21-oxa-5,20-diazahexacyclo[8.7.3.13,9.01,9.02,6.012,17]henicosa-12(17),13,15-trien-15-ol (1S,3aR,5aS,6R,11bR,11cS,12S)-3-benzyl-14-(cyclopropylmethyl)-1,2,3a,4,5,6,7,11c-octahydro-1H-6,11b-(immoethano)-1,5a-epoxynaphtho[1,2-e]indole-10,12-diol